Author:
López Quiñones Antonio J.,Shireman Laura M.,Wang Joanne
Funder
National Institutes of Health
NIGMS
NCATS
Subject
Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry
Reference22 articles.
1. Criteria for evaluation of disease extent by 123I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force;Matthay;Br. J. Cancer,2010
2. Azedra [package insert], Progenics Pharmaceuticals, Inc., New York, NY, 2018.
3. 131I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives;Parisi;Practical Applications, Seminars in Nuclear Medicine,2016
4. Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma;Pryma;J. Nucl. Med.,2019
5. Nothing but NET: A review of norepinephrine transporter expression and efficacy of 131 I-mIBG therapy;Streby;Pediatr. Blood Cancer,2015
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献